or Try an Advanced Search...

    Technical Analysis for CTMX - CytomX Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.33 9.02% 0.11
    CTMX closed up 9.02 percent on Monday, July 1, 2024, on 21 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical CTMX trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 9.02%
    Oversold Stochastic Weakness 9.02%
    MACD Bullish Signal Line Cross Bullish 5.56%
    Wide Bands Range Expansion 5.56%
    Oversold Stochastic Weakness 5.56%
    Hammer Candlestick Bullish 9.92%
    Lizard Bullish Bullish Day Trade Setup 9.92%
    Doji - Bullish? Reversal 9.92%
    Older End-of-Day Signals for CTMX ...

       Recent Intraday Alerts

    Alert Time
    Up 10% about 7 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above 10 DMA about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    10 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CTMX Chart by TradingView
    Basic chart:

    Profile

    CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., and ImmunoGen, Inc. to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical

    Is CTMX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
    Jun 17 CytomX Therapeutics promotes Chris Ogden to CFO
    Jun 17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
    Jun 5 (CTMX) - Analyzing CytomX Therapeutics's Short Interest
    Jun 5 Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
    Jun 5 Buy Alert: 3 Penny Stocks That Will Explode in 2024
    May 29 No Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
    May 28 CytomX upgraded at Piper Sandler on validation of cancer therapeutics platform
    May 22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
    May 16 CytomX Therapeutics Announces New Employment Inducement Grants
    See more CTMX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.85
    52 Week Low 1.04
    Average Volume 8,351,192
    200-Day Moving Average 1.69
    50-Day Moving Average 1.97
    20-Day Moving Average 1.43
    10-Day Moving Average 1.28
    Average True Range 0.14
    RSI (14) 39.02
    ADX 19.38
    +DI 22.01
    -DI 30.79
    Chandelier Exit (Long, 3 ATRs) 1.42
    Chandelier Exit (Short, 3 ATRs) 1.55
    Upper Bollinger Bands 1.79
    Lower Bollinger Band 1.08
    Percent B (%b) 0.36
    BandWidth 49.55
    MACD Line -0.19
    MACD Signal Line -0.21
    MACD Histogram 0.0171
    Fundamentals Value
    Market Cap 89.1 Million
    Num Shares 67 Million
    EPS -0.15
    Price-to-Earnings (P/E) Ratio -8.87
    Price-to-Sales 1.07
    Price-to-Book 5.04
    PEG Ratio -1.80
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.56
    Resistance 3 (R3) 1.54 1.45 1.52
    Resistance 2 (R2) 1.45 1.39 1.46 1.50
    Resistance 1 (R1) 1.39 1.36 1.42 1.41 1.49
    Pivot Point 1.30 1.30 1.32 1.31 1.30
    Support 1 (S1) 1.24 1.24 1.27 1.26 1.17
    Support 2 (S2) 1.15 1.21 1.16 1.16
    Support 3 (S3) 1.09 1.15 1.14
    Support 4 (S4) 1.11